Literature DB >> 7745003

Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas.

Y Greenman1, K Tordjman, E Kisch, N Razon, G Ouaknine, N Stern.   

Abstract

Pre- and postoperative anterior pituitary function was assessed in 26 subjects with nonfunctioning macroadenoma (NFMA) and in 15 acromegalic subjects with macroadenomas. Preoperatively, NFMA patients had a higher prevalence of secondary hypogonadism (78% vs. 40%; P < 0.05), hypothyroidism (23% vs. 0%; P = 0.06), and hypoadrenalism (43% vs. 7%; P = 0.02) compared to individuals with GH-secreting macroadenoma (GHMA). Patients with NFMA also had a higher prevalence of more severe pituitary failure compared with acromegalic patients; 56% of the patients in this group had more than one pituitary hormone axis impaired compared to only 8% in the acromegalic group. These differences could not be accounted for by tumor grade and/or stage. Transsphenoidal pituitary surgery led to a significant improvement in anterior pituitary function in the NFMA group. Nevertheless, the prevalence of pituitary deficiency postoperatively was still significantly greater in NFMA patients than in the acromegalic group (68% vs. 17%, respectively; P < 0.04). The results suggest that anterior pituitary function is better preserved in GHMA than in NFMA and that this difference is independent of tumor size. The mechanism underlying the lower rate of hypopituitarism in acromegalics with macroadenomas remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745003     DOI: 10.1210/jcem.80.5.7745003

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 2.  Optimal management of non-functioning pituitary adenomas.

Authors:  Yona Greenman; Naftali Stern
Journal:  Endocrine       Date:  2015-07-16       Impact factor: 3.633

Review 3.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Authors:  Georgia Ntali; John A Wass
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

4.  TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.

Authors:  D Somjen; K Tordjman; Y Greenman; F Kohen; G E Ouaknine; N Stern
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 5.  Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results.

Authors:  Pedro Carvalho; Eva Lau; Davide Carvalho
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

6.  Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.

Authors:  S S Damjanović; V P Popović; M S Petakov; M M Nikolic-Durović; M Z Doknić; M S Gligorović
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

7.  Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study.

Authors:  Chris Yedinak; Nadia Hameed; Marika Gassner; Jessica Brzana; Shirley McCartney; Maria Fleseriu
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

8.  Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes A Romijn
Journal:  Biologics       Date:  2008-09

9.  Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes.

Authors:  K Seejore; S A Alavi; S M Pearson; J M W Robins; B Alromhain; A Sheikh; P Nix; T Wilson; S M Orme; A Tyagi; N Phillips; R D Murray
Journal:  BMC Endocr Disord       Date:  2021-06-10       Impact factor: 2.763

10.  Severe growth hormone deficiency is rare in surgically-cured acromegalics.

Authors:  Shingo Fujio; Hiroshi Tokimura; Hirofumi Hirano; Ryosuke Hanaya; Fumikatsu Kubo; Shunji Yunoue; Manoj Bohara; Yasuyuki Kinoshita; Atsushi Tominaga; Hiroshi Arimura; Kazunori Arita
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.